Ono K, Fujiwara H. Tribute to Dr. Chuichi Kawai A Great Cardiologist in Japan. Circ J. 2024 Dec 6
Epub ahead of print. doi: 10.1253/circj.CJ-66-0232. PMID: 39647899.
Ono K. Twin Studies: Current Status and Future Directions. J Atheroscler Thromb. 2024 Nov 1
Epub 2024 Jul 24;31(11):1515-1516. doi: 10.5551/jat.ED268. PMID: 39048357.
Nakane E, Kato T, Tanaka N, Idouji M, Yamamoto Y, Saitou W, Hamaguchi T, Yano M, Harita T, Yamaji Y, Fukuda H, Haruna T, Inoko M. Cost-Effectiveness of the Self-Care Management System for Heart Failure. Circ Rep. 2024 Dec 7;7(1):31-36.
Ohno M, Shiomi H, Baba O, Yano M, Aizawa T, Nakano-Matsumura Y, Yamagami S, Kato M, Ohya M, Chen PM, Nagao K, Ando K, Yokomatsu T, Kadota K, Kouchi I, Inada T, Valentine C, Kitagawa T, Kurokawa M, Ohtsuru S, Morimoto T, Kimura T, Nishi E. Auxiliary roles of nardilysin in the early diagnosis of acute coronary syndrome: a prospective cohort study, the Nardi-ACS study. Intern Emerg Med. 2024 Apr
Epub 2024 Jan 17;19(3):649-659. doi: 10.1007/s11739-023-03508-0.
Nagao K, Kato T, Yaku H, Morimoto T, Aida K, Maruichi SK, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Seko Y, Inada T, Inoko M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Sato Y, Kuwahara K, Ozasa N, Ono K, Kimura T. Differential Prognostic Impact of Clinical Congestion between Preserved versus Reduced Ejection Fraction in Patients Hospitalized for Acute Decompensated Heart Failure: Findings from the Japanese Kyoto Congestive Heart Failure Registry. J Card Fail. 2024 Sep 30
Epub ahead of print;S1071-9164(24)00413-5. doi: 10.1016/j.cardfail.2024.08.060. PMID: 39357667.
Yamaji K, Kanenawa K, Morofuji T, Nishikawa R, Imada K, Kohjitani H, Watanabe H, Tazaki J, Taniwaki M, Koga S, Akashi R, Kubo S, Ohya M, Kikuchi T, Ohira H, Numasawa Y, Arikawa M, Iwama M, Kitai T, Kobayashi Y, Shiomi H, Tada T, Yamaji Y, Daidoji H, Ohtani H, Furukawa Y, Kadota K, Toyofuku M, Ando K, Ono K, Kimura T; PREDICTOR investigators. Serial Optical Coherence Tomography Assessment of Coronary Atherosclerosis and Long-Term Clinical Outcomes. J Am Heart Assoc. 2024 Nov 5
Epub 2024 Oct 22;13(21):e034458. doi: 10.1161/JAHA.123.034458. PMID: 39435729.
Kato ET, Hasegawa K, Ono K. The impact of sodium-glucose cotransporter 2 inhibitors in post-myocardial infarction management: insights from EMPACT-MI and DAPA-MI trials. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 4;10(6):486-487. doi: 10.1093/ehjcvp/pvae053. PMID: 38986503.
Watanabe H, Natsuaki M, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Kimura T, Ando K, Domei T, Suwa S, Ogita M, Isawa T, Takenaka H, Yamamoto T, Ishikawa T, Hisauchi I, Wakabayashi K, Onishi Y, Hibi K, Kawai K, Yoshida R, Suzuki H, Nakazawa G, Kusuyama T, Morishima I, Ono K, Kimura T. Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year followup of the STOPDAPT-3 trial. Eur Heart J. 2024 Dec 16;45(47):5042-5054. doi: 10.1093/eurheartj/ehae617. PMID: 39215959.
Watanabe H, Natsuaki M, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Hamatani Y, Ando K, Domei T, Suwa S, Ogita M, Isawa T, Takenaka H, Yamamoto T, Ishikawa T, Hisauchi I, Wakabayashi K, Onishi Y, Hibi K, Kawai K, Yoshida R, Suzuki H, Nakazawa G, Kusuyama T, Morishima I, Ono K, Kimura T; STOPDAPT-3 Investigators. Post-procedural Anticoagulation With Unfractionated Heparin in Acute Coronary Syndrome: Insight from the STOPDAPT-3 Trial. Am J Cardiol. 2024 Sep 1
Epub 2024 Jul 6;226:83-96. doi: 10.1016/j.amjcard.2024.07.002. PMID: 38972535.
Kaneda K, Yamashita Y, Morimoto T, Chatani R, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Ono K, Kimura T. Temporal Changes in Long-Term Outcomes of Venous Thromboembolism From the Warfarin Era to the Direct Oral Anticoagulant Era. J Am Heart Assoc. 2024 Aug 6
Epub 2024 Jul 31;13(15):e034412. doi: 10.1161/JAHA.124.034412. PMID: 39082425.
Taniguchi T, Morimoto T, Takeji Y, Shirai S, Ando K, Tabata H, Yamamoto K, Murai R, Osakada K, Sakamoto H, Tada T, Murata K, Obayashi Y, Amano M, Kitai T, Izumi C, Toyofuku M, Kanamori N, Miyake M, Nakayama H, Izuhara M, Nagao K, Nakatsuma K, Furukawa Y, Inoko M, Kimura M, Ishii M, Usami S, Nakazeki F, Shirotani M, Inuzuka Y, Ono K, Minatoya K, Kimura T; CURRENT AS Registry-2 Investigators. Low-Gradient Severe Aortic Stenosis: Insights From the CURRENT AS Registry-2. JACC Cardiovasc Interv. 2024 Nov 27
Epub ahead of print;S1936-8798(24)01257-3. doi: 10.1016/j.jcin.2024.09.044. PMID: 39708011.
Alexanian M, Padmanabhan A, Nishino T, Travers JG, Ye L, Pelonero A, Lee CY, Sadagopan N, Huang Y, Auclair K, Zhu A, An Y, Ekstrand CA, Martinez C, Teran BG, Flanigan WR, Kim CK, Lumbao-Conradson K, Gardner Z, Li L, Costa MW, Jain R, Charo I, Combes AJ, Haldar SM, Pollard KS, Vagnozzi RJ, McKinsey TA, Przytycki PF, Srivastava D. Chromatin remodelling drives immune cell-fibroblast communication in heart failure. Nature. 2024 Nov;635(8038):434-443.
Onishi N, Kaitani K, Nakagawa Y, Kobori A, Inoue K, Kurotobi T, Morishima I, Matsui Y, Yamaji H, Nakazawa Y, Kusano K, Shimizu Y, Hanazawa K, Tamura T, Izumi C, Morimoto T, Ono K, Kimura T, Shizuta S; KPAF Investigators. Radiofrequency Catheter Ablation for Atrial Fibrillation Patients on Hemodialysis (From the Kansai Plus Atrial Fibrillation Registry) Clinical Impact of Early Recurrence. Circ J. 2024 Jun 25
Epub 2024 Jan 11;88(7):1057-1064. doi: 10.1253/circj.CJ-23-0671. PMID: 38199253.
Nakatsuma K, Ozasa N, Ohno M, Ishiguro H, Minami M, Nishi E, Toi M, Ono K, Kimura T. Subclinical myocardial damage after anthracycline chemotherapy in Japanese patients with breast cancer. J Cardiol. 2024 Oct
Epub 2024 Mar 22;84(4):260-265. doi: 10.1016/j.jjcc.2024.03.005. PMID: 38521118.
Kawaji T, Shizuta S, Yaku H, Kaneda K, Yoneda F, Nishiwaki S, Tanaka M, Aizawa T, Hojo S, Nakatsuma K, Kato M, Yokomatsu T, Miki S, Ono K, Kimura T. Efficacy and safety of Saireito (TJ-114) in patients with atrial fibrillation undergoing catheter ablation procedures: A randomized pilot study. PLoS One. 2024 Aug 1;19(8):e0307854. doi: 10.1371/journal.pone.0307854. PMID: 39088481.
Kawaji T, Kaneda K, Yaku H, Bao B, Hojo S, Tezuka Y, Matsuda S, Shiomi H, Kato M, Yokomatsu T, Miki S, Ono K. Intracardiac energy inefficiency during decompensated and compensated heart failure. ESC Heart Fail. 2024 Sep 27
Epub ahead of print. doi: 10.1002/ehf2.15034. PMID: 39334555.
Nishikawa R, Yamashita Y, Morimoto T, Kaneda K, Chatani R, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Ono K, Kimura T; COMMAND VTE Registry‐2 Investigators. Selection of Home Treatment and Identification of Low-Risk Patients With Pulmonary Embolism Based on Simplified Pulmonary Embolism Severity Index Score in the Era of Direct Oral Anticoagulants. J Am Heart Assoc. 2024 Oct
Epub 2024 Sep 30;13(19):e034953. doi: 10.1161/JAHA.124.034953. PMID: 39344589.
Hamatani Y, Iguchi M, Kato T, Inuzuka Y, Tamaki Y, Ozasa N, Kawaji T, Esato M, Tsuji H, Wada H, Hasegawa K, Abe M, Kimura T, Ono K, Akao M; Fushimi AF Registry and KCHF Registry investigators. Importance of non-cardiovascular comorbidities in atrial fibrillation and heart failure with preserved ejection fraction. ESC Heart Fail. 2024 Sep 21
Epub ahead of print. doi: 10.1002/ehf2.15093. PMID: 39305136.
Yamashita Y, Fukasawa T, Takeda C, Takeuchi M, Ono K, Kawakami K. Clinical Characteristics and Outcomes of Patients With Venous Thromboembolism Receiving Edoxaban in the Real World. Circ J. 2024 Feb 22
Epub 2023 Dec 23;88(3):371-379. doi: 10.1253/circj.CJ-23-0818. PMID: 38143083.
Yamashita Y, Yachi S, Takeyama M, Nishimoto Y, Tsujino I, Nakamura J, Yamamoto N, Nakata H, Ikeda S, Umetsu M, Aikawa S, Hayashi H, Satokawa H, Okuno Y, Iwata E, Ogihara Y, Ikeda N, Kondo A, Iwai T, Yamada N, Ogawa T, Kobayashi T, Mo M; Clot-COVID Study Investigators. Prophylactic Anticoagulation and Thrombosis in Hospitalized Patients with Clinically Stable COVID-19 at Admission: From the Practice-Based Observational Study. Ann Vasc Dis. 2024 Mar 25;17(1):1-8.
Yamashita Y, Hira D, Morita M, Katsube Y, Takakura M, Tomotaki H, Tomotaki S, Xiong W, Shiomi H, Horie T, Ueshima S, Mizuno T, Terada T, Ono K. Potential treatment option of rivaroxaban for breastfeeding women: A case series. Thromb Res. 2024 May
Epub 2024 Apr 5;237:141-144. doi: 10.1016/j.thromres.2024.04.003. PMID: 38593524.
Yamashita Y, Morimoto T, Muraoka N, Shioyama W, Chatani R, Shibata T, Nishimoto Y, Ogihara Y, Doi K, Oi M, Shiga T, Sueta D, Kim K, Tanabe Y, Koitabashi N, Takada T, Ikeda S, Nakagawa H, Tsukahara K, Shoji M, Sakamoto J, Hisatake S, Ogino Y, Fujita M, Nakanishi N, Dohke T, Hiramori S, Nawada R, Kaneda K, Ono K, Kimura T; ONCO PE Trial Investigators. Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial). Circulation. 2024 Nov 18
Epub ahead of print. doi: 10.1161/CIRCULATIONAHA.124.072758. PMID: 39556015.
Shiba M, Kato T, Seko Y, Minamino-Muta E, Tanada Y, Kimura T, Ono K. Cobalt protoporphyrin promotes heme oxygenase 1 expression and ameliorates cardiac dysfunction in long-term fasting mice. Int J Cardiol. 2024 Jun 1
Epub 2024 Mar 14;404:131972. doi: 10.1016/j.ijcard.2024.131972. PMID: 38490272.
Ikeda S, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Ono K, Kimura T. Subclass phenotypes in patients with unprovoked venous thromboembolisms using a latent class analysis. Thromb Res. 2024 Jun
Epub 2024 Apr 19;238:27-36. doi: 10.1016/j.thromres.2024.04.017. PMID: 38653180.
Ikeda S, Yamashita Y, Ono K. Who requires longer-term anticoagulation therapy for venous thromboembolism from the perspective of precision medicine?. Eur Heart J Cardiovasc Pharmacother. 2024 Jul 16;10(4):270-271. doi: 10.1093/ehjcvp/pvae031. PMID: 38688868.
Ikeda S, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Ono K, Kimura T. Association Between White Blood Cell Counts at Diagnosis and Clinical Outcomes in Venous Thromboembolism From the COMMAND VTE Registry-2. Circ J. 2024 Oct 22
Epub ahead of print. doi: 10.1253/circj.CJ-24-0581. PMID: 39443129.
Takeji Y, Taniguchi T, Morimoto T, Shirai S, Kitai T, Tabata H, Ohno N, Murai R, Osakada K, Murata K, Nakai M, Tsuneyoshi H, Tada T, Amano M, Watanabe S, Shiomi H, Watanabe H, Yoshikawa Y, Nishikawa R, Obayashi Y, Yamamoto K, Toyofuku M, Tatsushima S, Kanamori N, Miyake M, Nakayama H, Nagao K, Izuhara M, Nakatsuma K, Inoko M, Fujita T, Kimura M, Ishii M, Usami S, Nakazeki F, Togi K, Inuzuka Y, Ando K, Komiya T, Ono K, Minatoya K, Kimura T; CURRENT AS registry-2 Investigators. Availability of transcatheter aortic valve implantation across hospitals and differences in strategies and clinical outcomes in patients with severe aortic stenosis. Cardiovasc Interv Ther. 2024 Nov 28
Epub ahead of print. doi: 10.1007/s12928-024-01054-w. PMID: 39604671.
Obayashi Y, Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Nishikawa R, Miyazawa A, Suzuki N, Suwa S, Kirigaya H, Wakabayashi K, Kawai K, Onishi Y, Morishima I, Okayama H, Uehara H, Hibi K, Ono K, Kimura T; STOPDAPT-3 Investigators. An aspirin-free strategy and optical coherence tomography observations after percutaneous coronary intervention: Insights from the STOPDAPT-3 trial. J Cardiol. 2024 Nov
Epub 2024 May 10;84(5):342-344. doi: 10.1016/j.jjcc.2024.05.002. PMID: 38735384.
Obayashi Y, Takeji Y, Taniguchi T, Morimoto T, Shirai S, Kitai T, Tabata H, Ohno N, Murai R, Osakada K, Murata K, Nakai M, Tsuneyoshi H, Tada T, Amano M, Watanabe S, Shiomi H, Watanabe H, Yoshikawa Y, Nishikawa R, Yamamoto K, Toyofuku M, Tatsushima S, Kanamori N, Miyake M, Nakayama H, Nagao K, Izuhara M, Nakatsuma K, Inoko M, Fujita T, Kimura M, Ishii M, Usami S, Nakazeki F, Togi K, Inuzuka Y, Ando K, Komiya T, Ono K, Minatoya K, Kimura T; CURRENT AS Registry-2 Investigators. Concomitant Mitral Regurgitation in Severe Aortic Stenosis Insights From the CURRENT AS Registry-2. Circ J. 2024 Nov 25
Epub 2024 May 9;88(12):1996-2007. doi: 10.1253/circj.CJ-24-0103. PMID: 38719572.
Obayashi Y, Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Nishikawa R, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Tokuyama H, Sakamoto H, Fujita T, Nanasato M, Okayama H, Nishikura T, Kirigaya H, Nishida K, Ono K, Kimura T; STOPDAPT-3 investigators. Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trial. Eur Heart J Cardiovasc Pharmacother. 2024 Aug 14;10(5):374-390. doi: 10.1093/ehjcvp/pvae009
Erratum in: Eur Heart J Cardiovasc Pharmacother. 2024 Aug 14;10(5):478. doi: 10.1093/ehjcvp/pvae046. PMID: 38285607.
Obayashi Y, Watanabe S, Kato ET, Shiomi H, Yamada C, Fuki M, Kawatou M, Sakaguchi H, Minatoya K, Ono K. Acquired von Willebrand Disease Associated With Severe Functional Mitral Regurgitation Improved by TEER. JACC Case Rep. 2024 Oct 2;29(19):102601. doi: 10.1016/j.jaccas.2024.102601. PMID: 39484311.
Obayashi Y, Miyake M, Takegami M, Amano M, Kitai T, Fujita T, Koyama T, Tanaka H, Ando K, Komiya T, Izumo M, Kawai H, Eishi K, Yoshida K, Kimura T, Nawada R, Sakamoto T, Shibata Y, Fukui T, Minatoya K, Tsujita K, Sakata Y, Fukuzawa M, Uehara K, Tamura T, Nishimura K, Furukawa Y, Izumi C; BPV-AF Registry Group. Bioprosthetic Valve Positions in Patients With Atrial Fibrillation – Insights From the BPV-AF Registry. Circ Rep. 2024 Oct 19;6(11):521-528.
Yamamoto K, Shiomi H, Morimoto T, Miyazawa A, Nakamura S, Suwa S, Fujita T, Kurita T, Sugawara S, Fujii K, Suematsu N, Isawa T, Matsuo H, Tanaka H, Shirota K, Hibi K, Kadota K, Ando K, Ono K, Kimura T; OPTIVUS-Complex PCI investigators. Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease and Diabetes. Am J Cardiol. 2024 Jul 15
Epub 2024 May 11;223:18-28. doi: 10.1016/j.amjcard.2024.04.054. PMID: 38740165.
Yamamoto K, Natsuaki M, Watanabe H, Morimoto T, Obayashi Y, Nishikawa R, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Tamura T, Kawahatsu K, Hayashi F, Akao M, Serikawa T, Mori H, Kawamura T, Hagikura A, Shibata N, Ono K, Kimura T; STOPDAPT-3 Investigators. An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2024 May 13;17(9):1119-1130. doi: 10.1016/j.jcin.2024.03.017. PMID: 38749592.
Yamamoto K, Natsuaki M, Watanabe H, Morimoto T, Obayashi Y, Nishikawa R, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Ikari Y, Kurita T, Kaitani K, Sugimoto A, Ogata N, Ikuta A, Hashimoto K, Ishibashi Y, Masuda K, Miyabe T, Ono K, Kimura T. An aspirin-free strategy for percutaneous coronary intervention in patients with diabetes: a pre-specified subgroup analysis of the STOPDAPT-3 trial. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 23
Epub ahead of print;pvae075. doi: 10.1093/ehjcvp/pvae075. PMID: 39444052.
Yamamoto K, Shiomi H, Nishikawa R, Morimoto T, Miyazawa A, Naganuma T, Suwa S, Fujita T, Domei T, Tatsushima S, Hamaguchi Y, Nishimoto Y, Matsuda K, Takayama Y, Kuribara J, Kirigaya H, Yoneda K, Shigetoshi M, Yokomatsu T, Kadota K, Ando K, Hibi K, Ono K, Kimura T; OPTIVUS-Complex PCI investigators. Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients with Multivessel Disease and Chronic Kidney Disease. Am J Cardiol. 2024 Dec 17
Epub ahead of print;S0002-9149(24)00873-7. doi: 10.1016/j.amjcard.2024.12.020. PMID: 39701404.
Yamamoto K, Takeji Y, Taniguchi T, Morimoto T, Shirai S, Kitai T, Tabata H, Ohno N, Murai R, Osakada K, Murata K, Nakai M, Tsuneyoshi H, Tada T, Amano M, Watanabe S, Shiomi H, Watanabe H, Yoshikawa Y, Nishikawa R, Obayashi Y, Toyofuku M, Tatsushima S, Kanamori N, Miyake M, Nakayama H, Nagao K, Izuhara M, Nakatsuma K, Inoko M, Fujita T, Kimura M, Ishii M, Usami S, Nakazeki F, Togi K, Inuzuka Y, Ando K, Komiya T, Ono K, Minatoya K, Kimura T; CURRENT AS Registry-2 Investigators. Safety of Calcium Channel Blockers in Patients With Severe Aortic Stenosis and Hypertension. Circ J. 2024 Dec 18
Epub ahead of print. doi: 10.1253/circj.CJ-24-0771. PMID: 39694497.
Chatani R, Yamashita Y, Morimoto T, Muraoka N, Shioyama W, Shibata T, Nishimoto Y, Ogihara Y, Doi K, Oi M, Shiga T, Sueta D, Kim K, Tanabe Y, Koitabashi N, Takada T, Ikeda S, Nakagawa H, Mitsuhashi T, Shoji M, Sakamoto J, Hisatake S, Ogino Y, Fujita M, Nakanishi N, Dohke T, Hiramori S, Nawada R, Kaneda K, Mushiake K, Yamamoto H, Kadota K, Ono K, Kimura T; ONCO PE Trial Investigators. Home Treatment for Active Cancer Patients With Low-Risk Pulmonary Embolism A Predetermined Companion Report From the ONCO PE Trial. Circ J. 2024 Mar 8
Epub ahead of print. doi: 10.1253/circj.CJ-24-0004. PMID: 38462535.
Chatani R, Yamashita Y, Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, Takada T, Ogihara Y, Nishikawa T, Ikeda N, Otsui K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Mushiake K, Kadota K, Ono K, Kimura T. Edoxaban for 12 vs. 3 months in cancer-associated isolated distal deep vein thrombosis according to different doses: insights from the ONCO DVT study. Eur Heart J Cardiovasc Pharmacother. 2024 Aug 14;10(5):422-431. doi: 10.1093/ehjcvp/pvae028. PMID: 38650055.
Nishiwaki S, Shizuta S, Kohjitani H, Ono K. Insight from the microelectrodes in case of two different types of premature ventricular contractions originating from left ventricular summit. Indian Pacing Electrophysiol J. 2024 JulAug;24(4):212-216
2024 May 8. doi: 10.1016/j.ipej.2024.05.001. PMID: 38729242.
Nishiwaki S, Shizuta S, Inoue T, Morinaga A, Yoneda F, Tanaka M, Aizawa T, Kohjitani H, Ono K. Prevalence and characteristics of atrioventricular nodal reentrant tachycardia with a bystander concealed nodoventricular/nodofascicular pathway. Heart Rhythm. 2024 Jun 26
Epub ahead of print;S1547-5271(24)02823-6. doi: 10.1016/j.hrthm.2024.06.049. PMID: 38942105.
Miyoshi Y, Lucena-Cacace A, Tian Y, Matsumura Y, Tani K, Nishikawa M, Narita M, Kimura T, Ono K, Yoshida Y. SMAD3 mediates the specification of human induced pluripotent stem cell-derived epicardium into progenitors for the cardiac pericyte lineage. Stem Cell Reports. 2024 Oct 8
Epub 2024 Sep 26;19(10):1399-1416. doi: 10.1016/j.stemcr.2024.08.008. PMID: 39332407.
Nakamura K, Yasushi Fuku, Kazushige Kadota. Intracardiac echocardiography-guided transcatheter aortic valve implantation without contrast. Eur Heart J Case Rep. 2024 Mar 28;8(4):ytae159.
Nakamura K, Tomohiko Taniguchi, Yutaka Furukawa. aemolytic anaemia after transcatheter aortic valve replacement. Eur Heart J. 2024 Apr 1;45(13):1181.
Baba D, MD1; Yamashita Y, MD, PhD1; Fukuda Y, MD1; Yamaji Y, MD, PhD1; Shiomi H, MD, PhD1; Horie T, MD, PhD1; Watanabe W, MD, PhD1; Ono K, MD, PhD1. A Case of Fat Embolism Syndrome Treated with Methylprednisolone. Internal medicine.
Gohbara M, Hibi K, Morimoto T, Kirigaya H, Yamamoto K, Ono K, Shiomi H, Ohya M, Yamaji K, Watanabe H, Amano T, Morino Y, Takagi K, Honye J, Matsuo H, Abe M, Kadota K, Ando K, Nakao K, Sonoda S, Suwa S, Kawai K, Kozuma K, Nakagawa Y, Ikari Y, Nanasato M, Hanaoka K, Tanabe K, Hata Y, Akasaka T, Kimura T; OPTIVUSComplex PCI investigators. Erratum to ‘SYNTAX Score and 1-Year Outcomes in the OPTIVUS-Complex PCI Study Multivessel Cohort’ [American Journal of Cardiology (2023) 431-441]. Am J Cardiol. 2024 Jan 15
Epub 2023 Dec 16;211:382. doi: 10.1016/j.amjcard.2023.12.013
Erratum for: Am J Cardiol. 2023 Oct 15;205:431-441. doi: 10.1016/j.amjcard.2023.08.043. PMID: 38114058.
Harada M, Su-Harada K, Kimura T, Ono K, Ashida N. Sustained activation of NF-κB through constitutively active IKKβ leads to senescence bypass in murine dermal fibroblasts. Cell Cycle. 2024 Feb
Epub 2024 Mar 10;23(3):308-327. doi: 10.1080/15384101.2024.2325802. PMID: 38461418.
Imamura T, Makiyama T*, Ozawa J, Sonoda K, Kato K, Aizawa T, Kashiwa A, Gao J, Huang H, Yamamoto Y, Kohjitani H, Aoki H, Watanabe S, Muraji S, Kojima T, Yoshinaga M, Ohno S, Suzuki H, Sumitomo N, Nakagawa Y, Ono K, Horie M, Kimura T *corresponding author. Sex-specific clinical course of young patients with Brugada syndrome. Eur Heart J. in press, 2025.
Inoue R, Watanabe H, Horie T, Ono K. Atrial fibrillation-induced cardiomyopathy presenting with bilateral intermittent claudication associated with intracardiac thrombi. BMJ Case Rep. 2024 Mar 6;17(3):e257151. doi: 10.1136/bcr-2023-257151. PMID: 38453224.
Mabuchi H, Nishikawa R, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Ono K, Nakagawa Y, Kimura T. Statins use and recurrent venous thromboembolism in the direct oral anticoagulant era: insight from the COMMAND VTE Registry-2. J Thromb Thrombolysis. 2024 Aug
Epub 2024 May 18;57(6):907-917. doi: 10.1007/s11239-024-03002-0. PMID: 38762713.
Maruyama T, Matsui S, Kobayashi R, Horii T, Oguri Y, Tsuzuki S, Horie T, Ono K, Hatada I, Sasaki T. Medium-chain triglyceride-specific appetite is regulated by the β-oxidation of medium-chain fatty acids in the liver. Am J Physiol Endocrinol Metab. 2024 May 1
Epub 2024 Apr 10;326(5):E735-E746. doi: 10.1152/ajpendo.00031.2024. PMID: 38597830.
Minami T, Yoshizawa T, Murase K, Komasa A, Aizawa T, Yamagami S, Tanaka M, Shizuta S, Sato S, Ono K, Hirai T, Kimura T, Chin K. Associations Among Sleep Apnea, Objective or Subjective Sleep Duration, and Recurrence of Atrial Fibrillation in Patients Who Undergo Radiofrequency Catheter Ablation for Persistent Atrial Fibrillation A Prospective Observational Study. Circ J. 2024 Nov 12
Epub ahead of print. doi: 10.1253/circj.CJ-24-0537. PMID: 39537150.
Nakamura M, Chonabayashi K, Narita M, Matsumura Y, Nishikawa M, Ochi Y, Nannya Y, Hishizawa M, Inoue D, Delwel R, Ogawa S, Takaori-Kondo A, Yoshida Y. Modelling and drug targeting of a myeloid neoplasm with atypical 3q26/MECOM rearrangement using patient-specific iPSCs. Br J Haematol. 2024 Oct
Epub 2024 Aug 26;205(4):1430-1443. doi: 10.1111/bjh.19720. PMID: 39187468.
Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Yamada M, Wakatsuki T, Nozaki Y, Kitahara H, Kato R, Kawai R, Kobayashi Y, Ishii M, Goto Y, Ono K, Kimura T. Aspirin-Free Strategy for Percutaneous Coronary Intervention in Patients With Oral Anticoagulation: Prespecified Subgroup Analysis From the STOPDAPT-3 Trial. J Am Heart Assoc. 2024 Aug 6
Epub 2024 Jul 26;13(15):e034201. doi: 10.1161/JAHA.123.034201. PMID: 39056346.
Okuda R, Ochi Y, Saiki R, Yamanaka T, Terao C, Yoshizato T, Nakagawa MM, Zhao L, Ohyashiki K, Hiramoto N, Sanada M, Handa H, Kasahara S, Miyazaki Y, Sezaki N, Shih LY, Kern W, Kanemura N, Kitano T, Imashuku S, Watanabe M, Creignou M, Chonabayashi K, Usuki K, Ishikawa T, Gotoh A, Atsuta Y, Shiraishi Y, Mitani K, Chiba S, Takaori-Kondo A, Miyano S, Kamatani Y, Haferlach T, Hellström-Lindberg E, Matsuda K, Yoshida Y, Makishima H, Nannya Y, Ogawa S. Genetic analysis of myeloid neoplasms with der(1;7)(q10;p10). Leukemia. 2024 Dec 23. doi: 10.1038/s41375-024-02494-2.
Sakao S, Kondoh Y, Kinoshita H, Nishiyama O, Ogo T, Tanabe N, Minatsuki S, Nakayama K, Taniguchi Y, Takahashi K, Takatsu M, Ogura T. Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease. Respir Investig. 2024 Nov;62(6):980-986. doi: 10.1016/j.resinv.2024.07.020.
Takabayashi K, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Ono K, Kimura T; COMMAND VTE Registry-2 Investigators. Clinical characteristics and short-term outcomes of patients with critical acute pulmonary embolism requiring extracorporeal membrane oxygenation: from the COMMAND VTE Registry-2. J Intensive Care. 2024 Nov 5;12(1):45. doi: 10.1186/s40560-024-00755-x. PMID: 39497225.
Teramoto K, Nochioka K, Sakata Y, Kato ET, Nishimura K, Shimokawa H, Yasuda S; SUPPORT Trial Investigators. Growth differentiation factor-15 and metabolic features in chronic heart failure: Insights from the SUPPORT Trial -GDF15 across the BMI spectrum. Int J Cardiol. 2024 Jul 15
Epub 2024 Apr 23;2608:33:00. doi: 10.1016/j.ijcard.2024.132093. PMID: 3866380.
Lucena-Cacace A, Tian Y, Yoshida Y. Generation of 3D-Multicellular Human iPSC-Heart Organoids for the Noninvasive Assessment of Cardiac Fibrosis. Methods Mol Biol. 2024;2803:35-48. doi: 10.1007/978-1-0716-3846-0_3. PMID: 3867688.
Otero-Albiol D, Santos-Pereira JM, Lucena-Cacace A, Clemente-González C, Muñoz-Galvan S, Yoshida Y, Carnero A. Hypoxia-induced immortalization of primary cells depends on Tfcp2L1 expression. Cell Death Dis. 2024 Feb 28;15(2):177. doi: 10.1038/s41419-024-06567-z.
Xiong W, Yamashita Y, Morimoto T, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Chen PM, Murata K, Tsuyuki Y, Nishimoto Y, Sakamoto J, Togi K, Mabuchi H, Takabayashi K, Kato T, Ono K, Kimura T; COMMAND VTE Registry Investigators. Initial hemodynamic status and Acute Mortality in Cancer patients with Acute Pulmonary Embolism: from the COMMAND VTE Registry. J Thromb Thrombolysis. 2024 Oct
Epub 2024 Jul 9;57(7):1183-1192. doi: 10.1007/s11239-024-03009-7. PMID: 38981977.
Xiong W, Yamashita Y, Morimoto T, Muraoka N, Umetsu M, Nishimoto Y, Takada T, Ogihara Y, Nishikawa T, Ikeda N, Otsui K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Ono K, Kimura T; ONCO DVT Study Investigators. Utility of the modified Ottawa score for identification of more preferable candidates of extended anticoagulation therapy in cancer-associated isolated distal deep vein thrombosis: insight from the ONCO DVT Study. J Thromb Haemost. 2024 Dec
Epub 2024 Sep 14;22(12):3542-3551. doi: 10.1016/j.jtha.2024.09.003. PMID: 39284385.
Baudic M, Murata H, Bosada FM, Melo US, Aizawa T, Lindenbaum P, van der Maarel LE, Guedon A, Baron E, Fremy E, Foucal A, Ishikawa T, Ushinohama H, Jurgens SJ, Choi SH, Kyndt F, Le Scouarnec S, Wakker V, Thollet A, Rajalu A, Takaki T, Ohno S, Shimizu W, Horie M, Kimura T, Ellinor PT, Petit F, Dulac Y, Bru P, Boland A, Deleuze JF, Redon R, Le Marec H, Le Tourneau T, Gourraud JB, Yoshida Y, Makita N, Vieyres C, Makiyama T, Mundlos S, Christoffels VM, Probst V, Schott JJ, Barc J. TAD boundary deletion causes PITX2-related cardiac electrical and structural defects. Nat Commun. 2024 Apr 20;15(1):3380. doi: 10.1038/s41467-024-47739-x.
Tanaka M, Kohjitani H, Yamamoto E, Morimoto T, Kato T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Seko Y, Shiba M, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Okuno Y, Kimura T, Ono K; KCHF Study Investigators. Development of interpretable machine learning models to predict in-hospital prognosis of acute heart failure patients. ESC Heart Fail. 2024 Oct
Epub 2024 May 15;11(5):2798-2812. doi: 10.1002/ehf2.14834. PMID: 38751135.
Horie T, Ono K. VERVE-101: a promising CRISPR-based gene editing therapy that reduces LDL-C and PCSK9 levels in HeFH patients. Eur Heart J Cardiovasc Pharmacother. 2024 Feb 3;10(2):89-90. doi: 10.1093/ehjcvp/pvad103. PMID: 38142221.
Shiomi H, Hasegawa K, Ono K. What is optimal dual anti-platelet therapy duration after percutaneous coronary intervention?. Eur Heart J Cardiovasc Pharmacother. 2024 Jan 5
2023 Nov 9 Epub ahead of print;10(1):10. doi: 10.1093/ehjcvp/pvad084. PMID: 37950560.
Kato ET, Ono K, Lewis BS. SGLT2 inhibitors in acute myocardial infarction: what can we learn from the DAPA-MI trial? More news from American Heart Association Scientific Meeting. Eur Heart J Cardiovasc Pharmacother. 2024 Feb 23
2023 Dec 7 Epub ahead of print;10(2):95-97. doi: 10.1093/ehjcvp/pvad099. PMID: 38061802.
Tsuji S, Otani C, Horie T, Watanabe S, Baba O, Sowa N, Ide Y, Kashiwa A, Makiyama T, Imai H, Nakashima Y, Yamasaki T, Xu S, Matsushita K, Suzuki K, Zou F, Kume E, Hasegawa K, Kimura T, Kakizuka A, Ono K. KUS121, a VCP modulator, has an ameliorating effect on acute and chronic heart failure without calcium loading via maintenance of intracellular ATP levels. Biomed Pharmacother. 2024 Jan
Epub 2023 Dec 12;170:115850. doi: 10.1016/j.biopha.2023.115850. PMID: 38091636.
Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Ando K, Domei T, Suwa S, Ogita M, Isawa T, Takenaka H, Yamamoto T, Ishikawa T, Hisauchi I, Wakabayashi K, Onishi Y, Hibi K, Kawai K, Yoshida R, Suzuki H, Nakazawa G, Kusuyama T, Morishima I, Ono K, Kimura T. An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial. Circulation. 2024 Feb 20
Epub 2023 Nov 23;149(8):585-600. doi: 10.1161/CIRCULATIONAHA.123.066720
Erratum in: Circulation. 2024 May 14;149(20):e1189-e1190. doi: 10.1161/CIR.0000000000001255. PMID: 37994553.
Watanabe H, Morimoto T, Natsuaki M, Yamamoto K, Obayashi Y, Nishikawa R, Ando K, Ono K, Kadota K, Suwa S, Morishima I, Yoshida R, Hata Y, Akao M, Yagi M, Suematsu N, Morino Y, Yokomatsu T, Takamisawa I, Noda T, Doi M, Okayama H, Nakamura Y, Hibi K, Sakamoto H, Noguchi T, Kimura T; STOPDAPT-2 Investigators. Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention. J Am Coll Cardiol. 2024 Jan 2
Epub 2023 Oct 23;83(1):17-31. doi: 10.1016/j.jacc.2023.10.013. PMID: 37879491.
Kohjitani H, Koshimizu H, Nakamura K, & Okuno Y. Recent developments in machine learning modeling methods for hypertension treatment. Hypertens. Res.1–8 (2024). doi: 10.1038/s41440-023-01547-w.
Nakanishi-Koakutsu M, Miki K, Naka Y, Sasaki M, Wakimizu T, Napier SC, Okubo C, Narita M, Nishikawa M, Hata R, Chonabayashi K, Hotta A, Imahashi K, Nishimoto T, Yoshida Y. CD151 expression marks atrial- and ventricular- differentiation from human induced pluripotent stem cells. Commun Biol. 2024 Feb 28;7(1):231. doi: 10.1038/s42003-024-05809-2.
Kashiwa A, Itoh H, Makiyama T, Wada Y, Ozawa J, Kato K, Fukuyama M, Nakajima T, Ohno S, Horie M. Clinical characterization of type 1 long QT syndrome caused by C-terminus Kv7.1 variants. Heart Rhythm. 2024 Feb 15;21(7):1113-1120.
Xu S, Shiomi H, Yamashita Y, Koyama S, Horie T, Baba O, Kimura M, Nakashima Y, Sowa N, Hasegawa K, Suzuki A, Suzuki Y, Kimura T, Ono K. CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing. PLoS One. 2024 Mar 20;19(3):e0297231. doi: 10.1371/journal.pone.0297231. PMID: 38507394.